// App-Quantinova.ai

M4300 2015 AHA : Impact of the GNB3 C825T Polymorphism on Heart Failure Survival

Researchers

Presenter

  • Karen Hanley-Yanez

Principal Investigators

  • Indrani Halder

  • Richard Sheppard

Medical Centers

  • Jewish General Hospital, Montreal, QC, Canada

  • University of Pittsburgh Medical Center, Pittsburgh, PA

  • University of Pittsburgh, Pittsburgh, PA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • hydralazine

  • hydralazine Injection

  • Isosorbide Mononitrate

  • Grace

Outcome

  • N/A

Study Design

  • fixed dose

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved